Skip to main content
. 2014 Nov;35(11):2192–2196. doi: 10.3174/ajnr.A4011

Individual patient information on demographics, histology, treatment, and outcome

Patient No. Age (y)/Sex Diagnosis ADC Value (×10−6 mm2/s) ADC Ratio Treatment F/U (y) Treatment Response TTP (y) F/U Results
1 4.7/F PXA XRT/Chemo 14.8 PD 8.6 Alive
2 4.8/M PXA 838 1.06 Sx (3)/XRT 5.0 PD 2.7 Alive
3 7.1/F Anap. PXA Sx (2)/XRT/Chemo 0.5 PD 0.2 Died
4 9.3/F PXA 928 1.24 Sx 7.7 CR n/a Alive
5 4.5/F PXA 668 0.85 Sx Lost to F/U
6 6.9/M PXA 1189 1.47 Sx (3) 9.6 PD 3.8 Alive
7 16.1/M PXA 889 1.28 Sx 3.4 CR n/a Alive
8 6.1/M Anap. PXA 825 0.75 Sx/XRT/Chemo 4.0 CR n/a Alive
9 11.6/M PXA 762 1.32 Sx Lost to F/U
10 14.0/F PXA Sx/XRT/Chemo 8.2 PD 0.8 Died
11 13.0/M Anap. PXA Sx/XRT/Chemo 2.5 CR n/a Alive

Note:—Anap. indicates anaplastic; Chemo, chemotherapy; CR, complete remission; F/U, follow-up; PD, progressive disease; Sx, surgery; XRT, radiotherapy.